loader
Find a Test

Levetiracetam (Keppra) Level

Order Code
11251017
CPT
80177
Test Details
Synonyms

Keppra

TAT

24 hours

Methodology

Competitive Enzymatic Immunoassay

Reference Interval

10 - 40 µg/mL

Remarks

Trough (pre-dose) specimens are preferred and, while tubes containing gel separators will not be rejected, they may cause falsely low results due to the gel absorbing the drug.

Performing Location

Accredited NRL Laboratory

Testing Frequency

Daily

Test Overview

Levetiracetam (Keppra), is a broad-spectrum antiepileptic drug widely used for the management of focal-onset seizures, generalized tonic–clonic seizures, and myoclonic seizures in both adults and children.

Its clinical utility lies in its rapid onset of action, favourable safety profile, minimal drug–drug interactions, and predictable pharmacokinetics, making it suitable for acute seizure control, chronic therapy, and adjunctive treatment in refractory epilepsy.

Specimen Type

Li-Hep Plasma or Serum

Volume

0.5 mL

Specimen Container

Lithium Heparin Plasma (Green Top, no gel) or Plain Serum Tube (Red Top, no gel)

Patient Preparation

No special preparation is required for this test; you may eat and drink as normal, unless instructed otherwise by your healthcare provider. However, a trough (pre-dose) sample is preferred.

Collection

This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.

Specimen Stability
Temperature Period
Refrigerated 7 days
Frozen 4 weeks
Order Code
11251017
CPT
80177
Test Details
Synonyms

Keppra

TAT

24 hours

Methodology

Competitive Enzymatic Immunoassay

Reference Interval

10 - 40 µg/mL

Remarks

Trough (pre-dose) specimens are preferred and, while tubes containing gel separators will not be rejected, they may cause falsely low results due to the gel absorbing the drug.

Performing Location

Accredited NRL Laboratory

Testing Frequency

Daily

Test Overview

Levetiracetam (Keppra), is a broad-spectrum antiepileptic drug widely used for the management of focal-onset seizures, generalized tonic–clonic seizures, and myoclonic seizures in both adults and children.

Its clinical utility lies in its rapid onset of action, favourable safety profile, minimal drug–drug interactions, and predictable pharmacokinetics, making it suitable for acute seizure control, chronic therapy, and adjunctive treatment in refractory epilepsy.

Specimen Type

Li-Hep Plasma or Serum

Volume

0.5 mL

Specimen Container

Lithium Heparin Plasma (Green Top, no gel) or Plain Serum Tube (Red Top, no gel)

Patient Preparation

No special preparation is required for this test; you may eat and drink as normal, unless instructed otherwise by your healthcare provider. However, a trough (pre-dose) sample is preferred.

Collection

This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.

Specimen Stability
Temperature Period
Refrigerated 7 days
Frozen 4 weeks